Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.

Open access

Abstract

Prospective longitudinal study of methylphenidate-treated boys with ADHD followed into adulthood.

Overview

CoChat Summary

TL;DR

In a prospective follow-up of methylphenidate-treated boys with ADHD, later age at treatment initiation was associated with higher risk of non-alcohol substance use disorder, but this association was explained by later antisocial personality disorder. Early methylphenidate treatment did not increase risk for substance use disorder and may have beneficial long-term effects.

Key findings

  • Later age at first methylphenidate treatment significantly predicted Non-Alcohol SUD (Wald χ²=4.24, p<.04); those who developed Non-Alcohol SUD started treatment at a mean of 9.10 ± 1.74 years versus 8.52 ± 1.55 years for those who did not (t(174)=2.31, p=.02).
  • Late-treated probands (treatment began at ages 8–12) had higher lifetime SUD rates than early-treated probands (ages 6–7) (44% vs. 27%, Wald χ²=5.38, p<.02) and than non-ADHD comparisons (44% vs. 29%, Wald χ²=6.36, p<.02); early-treated probands did not differ from comparisons (27% vs. 29%, Wald χ²=0.12, p>.10).
  • Antisocial personality disorder explained the treatment-initiation–SUD relationship: age at initiation remained associated with APD when SUD was covaried (Wald χ²=7.67, p<.01), but the initiation–SUD association disappeared when APD was controlled (Wald χ²=0.09, p=.76).
  • Age at initiation was unrelated to mood disorders (Wald χ²=1.35, p>.10) or anxiety disorders (Wald χ²=0.40, p>.10).

Methods

  • Prospective longitudinal study of 176 methylphenidate-treated white boys (ages 6–12) with ADHD but without conduct disorder, plus 178 non-ADHD male comparisons matched for age, social class, and geographic residence; follow-ups occurred at mean ages 18.4 ± 1.3 years (94% retention) and 25.3 ± 1.3 years (85% retention).
  • Cox proportional hazards models included nine childhood predictors: age at methylphenidate initiation, total cumulative dose, treatment duration, Full Scale IQ, severity of hyperactivity, socioeconomic status, and lifetime mental disorder in mother, father, or either parent; outcomes were Any SUD, Alcohol SUD, Non-Alcohol SUD, and Stimulant SUD, with post-hoc analyses for antisocial personality disorder, mood, and anxiety disorders.
  • Diagnoses were made by clinicians blind to childhood status using adolescent and adult interviews, including a modification of the Diagnostic Interview Schedule, the Teenager Or Young Adult Schedule, the Schedule for the Assessment of Conduct, Hyperactivity, Anxiety, Mood, and Psychoactive Substances, and parent interviews.

Limitations

  • The paper states it is an experiment of nature using a referred clinical sample; age at referral was not experimentally controlled, so unidentified non-random factors related to treatment initiation may have contributed, and replication is essential.
  • The paper states the sample was ethnically homogeneous, excluded females, and had a minimum age of 6, restricting generalizability to clinic-referred 6–12 year old white males; it also cannot differentiate effects of stimulant medication from effects of age at referral or duration of untreated ADHD.
  • Evident from the text: the observational design cannot establish causality, and despite controlling for several childhood and parent variables, residual confounding by unmeasured family or parenting factors remains possible.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2008.07091465

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

0 Valid · 0 Not valid · 14 Not checked · 67 Own results and interpretations

48 more claims

Create a free account to see all 81 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 23
  • The quote only partly states this claim. 1
  • It may state two separate claims as one. 9

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Consistentt(174) = 2.31reported p = .02 · recomputed p = .022

    “t (174) = 2.31, p = .02”

  • Consistentr(176) = 0.05reported p = .49 · recomputed p = .507

    “r(176) = .05, p = .49”

  • Consistentr(176) = -0.05reported p = .54 · recomputed p = .507

    “r(176) = −.05, p = .54”

  • Consistentr(176) = -0.06reported p = .45 · recomputed p = .426

    “r(176) = −.06, p = .45”

4 of 4

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Citations

Cites

Show all 44 references

Research works printed but not linked: 8

  1. Milberger S, 1997, Am J Addict, 6, 318
  2. Schenk S, 1998, NIDA Res Monogr, 169, 56
  3. Loney J, 2002, Attention Deficit Hyperactivity Disorder: State of the Science Best Practices, 1
  4. Gittelman R, 1980, Hyperactive Children, 221
  5. Wechsler D, 1949, Wechsler Intelligence Scale for Children
  6. Conners CK, 1973, Psychopharmacol Bull, 9, 24
  7. Mannuzza S, 1987, Hyperactivity, Anxiety, Mood, and Psychoactive Substances (CHAMPS).
  8. Hosmer DW, 1999, Lemeshow S: Applied Survival Analysis

Cited by

See all 265

Metadata

Authors
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X.
Affiliations
New York University (US)
Venue
American Journal of Psychiatry
Published
2008-05
Volume
165
Issue
5
Pages
604-609
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2142868627
Cited by
263
References
44
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 13 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 15 · 2018: 7 · 2017: 11 · 2016: 14 · 2015: 24 · 2014: 22 · 2013: 19 · 2012: 29
FWCI
15.92
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (MH-18579, R01MH018579)
  • National Institute on Drug Abuse (DA-16979, R01DA016979)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
methylphenidate, attention deficit hyperactivity disorder, age at treatment initiation, stimulant medication, substance use disorders, alcoholism, antisocial personality disorder, long-term outcomes, childhood ADHD
MeSH terms
Adolescent, Adult, Age Factors, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Follow-Up Studies, Humans, Male, Methylphenidate, Parents, Prospective Studies, Surveys and Questionnaires, Observer Variation, Incidence, Prevalence, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. https://app.cochat.ai/papers/10.1176/appi.ajp.2008.07091465
The paper
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008). Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2008.07091465

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.